Home / Telmisartan and Diuretics / Canada
CA ATC C09DA07 · updated 2 Nov 2026
Telmisartan and Diuretics shortage in Canada
Is there a Telmisartan and Diuretics shortage in Canada?
Yes. As of 2 Nov 2026, 6 Telmisartan and Diuretics products are reported short in Canada, the first since 22 May 2017. The company estimate for the return is 27 Nov 2026. Main reason: manufacturing problem.
Also short in Italy, Spain, Czechia. All countries.
Affected products in Canada
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| CA | APO-TELMISARTAN/HCTZ (100 BTL) | APOTEX INC | 22 May 2017 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| CA | TEVA-TELMISARTAN HCTZ (PP30) | TEVA CANADA LIMITED | 16 Jul 2025 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| CA | TEVA-TELMISARTAN HCTZ (100) | TEVA CANADA LIMITED | 12 Nov 2025 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| CA | TEVA-TELMISARTAN HCTZ (100) | TEVA CANADA LIMITED | 4 Feb 2026 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| CA | TEVA-TELMISARTAN HCTZ (PP and 50's) | TEVA CANADA LIMITED | 8 Apr 2026 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| CA | JAMP TELMISARTAN-HCT (100) | JAMP PHARMA CORPORATION | 15 Sep 2026 | 27 Nov 2026 | Manufacturing problem Disruption of the manufacture of the drug |
Source
Health Canada, Health Product Shortages Canada. Official list. Mandatory company reports since 2017: actual and anticipated shortages, plus products about to be discontinued.